產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-PBLD抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購(gòu)！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-PBLD抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-PBLD
Cat. Number:
Anti-PBLD抗體KL-9032R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
MAWDBP (MAWD binding protein), also known as PBLD (phenazine biosynthesis-like protein domain containing) or MAWBP, is a 288 amino acid protein that belongs to the phenazine biosynthesis-like protein (PhzF) Anti-PBLD抗體family. It has been suggested that MAWDBP is the only representative of the PhzF family in the human genome. Expressed in most tissues, MAWDBP is a WD-40 repeat-containing β-propeller protein believed to participate in the MAPK signaling pathway. Involved in multiple basic cellular functions, expression of MAWDBP is elevated in several disease processes, including insulin resistance, folate deficiency and hypotension. It is thought that MAWDBP may also be involved in carcinogenesis.
Also known as:
MAWBP; MAWD binding protein; Anti-PBLD抗體MAWD-binding protein; MAWDBP; PBLD; PBLD_HUMAN; Phenazine biosynthesis like domain containing protein; Phenazine biosynthesis like protein domain containing; Phenazine biosynthesis-like domain-containing protein; Unknown protein 32 from 2D page of liver tissue; Unknown protein 32 from 2D-page of liver tissue; FLJ14767; FLJ35507; OTTHUMP00000019698; OTTHUMP00000082489.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Cow, Anti-PBLD抗體Horse, .
●
Immunogen: KLH conjugated synthetic peptide derived from human PBLD/MAWBP.
●
Predicted Molecular Weight: 32kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:50-200
Not yet tested in other applications. Anti-PBLD抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-PBLD抗體
Optimal working dilutions must be determined by the end user.
